×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
Hepatitis C, Chronic
0.400
Therapeutic
CTD_human
Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation.
18294165
2008
×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
Hepatitis C, Chronic
0.400
Therapeutic
CTD_human
Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
15951019
2006
×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
Hepatitis C, Chronic
0.400
Therapeutic
CTD_human
Autoimmune disorders during interferon therapy in a patient with chronic hepatitis C infection: how many of them can be observed in a single patient?
16633111
2006
×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
Hepatitis C, Chronic
0.400
Therapeutic
CTD_human
Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells.
16476009
2006
×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
Hepatitis C, Chronic
0.400
Therapeutic
CTD_human
Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
15751770
2005
×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
Hepatitis C, Chronic
0.400
Therapeutic
CTD_human
Twenty-three patients with chronic hepatitis C were treated with interferon alpha 2b plus RBV with (NYT group) or without (control group) NYT by a randomized selection.
15996025
2005
×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
Hepatitis C, Chronic
0.400
Therapeutic
CTD_human
Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C.
15293138
2004
×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
Hepatitis C, Chronic
0.400
Therapeutic
CTD_human
Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study.
11454181
2001
×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
Hepatitis C, Chronic
0.400
Therapeutic
CTD_human
Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.
9860407
1998
×
Entrez Id:
3440
Gene Symbol:
IFNA2
IFNA2
Hepatitis C, Chronic
0.400
Therapeutic
CTD_human
Thirty-one patients with chronic hepatitis C were randomized to receive 3 million units of interferon-alpha 2b subcutaneously three times per week and either 13 to 15 mg/kg/day ursodeoxycholic acid or placebo orally for 6 months.
9563925
1998